699-P: Prerandomization Factors Associated with Time-in-Target Glucose Range with Hybrid Closed-Loop Use in a Six-Month Randomized Controlled Trial in Adults with Type 1 Diabetes

Background: In our published trial in 120 adults with type 1 diabetes (T1D), allocation to hybrid closed loop (HCL) increased Continuous Glucose Monitoring (CGM) Time in Range ((TIR), 70-180mg/dL) by 15 percentage points vs. user-determined insulin dosing. Recommended TIR is >70%. Objective: To e...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2021-06, Vol.70 (Supplement_1)
Hauptverfasser:	JENKINS, ALICIA, JANUSZEWSKI, ANDRZEJ S., KIRBY, ADRIENNE, MCAULEY, SYBIL A., LEE, MELISSA H., PALDUS, BARBORA, VOGRIN, SARA, BOCK, MARTIN DE, BURT, MORTON, COHEN, NEALE, COLMAN, PETER G., DAVIS, ELIZABETH A., HOLMES-WALKER, JANE, KEECH, ANTHONY C., MACISAAC, RICHARD, SIMS, CATRIONA M., SUNDARARAJAN, VIJAYA, TRAWLEY, STEVEN, WARD, GLENN M., JONES, TIM, O’NEAL, DAVID N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adults Blood glucose Clinical outcomes Closed loop systems Diabetes Diabetes mellitus (insulin dependent) Disease management Dosage Glucose Glucose monitoring Insulin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!